Sutro Biopharma, Inc. (STRO)
23.78
-1.09
(-4.38%)
USD |
NASDAQ |
Apr 02, 16:00
23.63
-0.15
(-0.63%)
After-Hours: 20:00
Sutro Biopharma EPS Diluted (Quarterly) : -5.447 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rhythm Pharmaceuticals, Inc. | -0.7302 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -46.76M |
| Revenue (Quarterly) | 11.65M |
| Total Expenses (Quarterly) | 58.41M |
| Enterprise Value | 487.75M |
| Gross Profit Margin (Quarterly) | 86.06% |
| Profit Margin (Quarterly) | -401.5% |
| Earnings Yield | -63.82% |
| Normalized Earnings Yield | -51.22 |